Marksans Pharma Ltd. - Research Center
524404 MARKSANS Group (A) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | |
|---|---|---|---|---|---|
| Sales | 386.71 | 329.41 | 342.22 | 316.07 | 293.51 |
| Operating profit | 64.06 | 45.38 | 54.69 | 59.03 | 52.05 |
| Interest | 0.49 | 2.11 | 1.96 | 1.83 | 2.11 |
| Gross profit | 112.12 | 83.74 | 72.44 | 79.73 | 62.95 |
| EPS (Rs) | 1.67 | 1.47 | 1.16 | 1.38 | 1.11 |
Half yearly
results in details
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | |
|---|---|---|---|---|---|
| Other income | 48.55 | 40.47 | 19.71 | 22.54 | 13.01 |
| Stock adjustment | -3.65 | -3.91 | 3.40 | 0.49 | 0.07 |
| Raw material | 185.62 | 170.25 | 163.64 | 164.35 | 137.29 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 35.16 | 26.87 | 30.50 | 29.96 | 25.13 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 105.53 | 90.82 | 89.99 | 62.24 | 78.97 |
| Provisions made | - | - | - | - | - |
| Depreciation | 13.22 | 9.05 | 9.13 | 8.53 | 7.01 |
| Taxation | 23.42 | 15.25 | 15.82 | 14.70 | 10.34 |
| Net profit / loss | 75.48 | 59.44 | 47.48 | 56.50 | 45.59 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 45.32 | 40.42 | 40.93 | 40.93 | 40.93 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 16.56 | 13.78 | 15.98 | 18.68 | 17.73 |
| GPM (%) | 25.76 | 22.64 | 20.01 | 23.55 | 20.54 |
| NPM (%) | 17.34 | 16.07 | 13.12 | 16.69 | 14.87 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis